| HNRGX | VENAX | HNRGX / VENAX | |
| Total Expense Ratio | 2.53 | 0.09 | 2,811% |
| Annual Report Gross Expense Ratio | 2.70 | 0.09 | 3,000% |
| Fund Existence | 13 years | 22 years | - |
| Gain YTD | 33.012 | 42.553 | 78% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2500 | 100000 | 3% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 16.8M | 12.4B | 0% |
| Annual Yield % from dividends | 0.42 | 2.40 | 17% |
| Returns for 1 year | 46.51 | 48.08 | 97% |
| Returns for 3 years | 66.23 | 46.44 | 143% |
| Returns for 5 years | 227.30 | 181.39 | 125% |
| Returns for 10 years | 141.31 | 85.74 | 165% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| MIINX | 20.96 | 0.20 | +0.96% |
| BNY Mellon International Inv | |||
| BERCX | 18.97 | 0.12 | +0.64% |
| Carillon Chartwell Mid Cap Value I | |||
| AEYRX | 40.12 | 0.22 | +0.55% |
| American Century Disciplined Core Eq R | |||
| GSBGX | 25.61 | 0.14 | +0.55% |
| GMO Small Cap Quality Fund Class VI | |||
| VGRTX | 98.02 | 0.45 | +0.46% |
| JPMorgan US Value R2 | |||